Related Experiment Video
Updated: Jan 14, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Hesperetin-Attenuated Diabetes-Induced Vascular Endothelial Injury, Associated with Gut Microbiota Modulation and
Danyang Zhang1, Xiaoshi He1, Hui Jiang1
1MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian 116024, China.
Abstract:
Cardiovascular complications arising from vascular endothelial injury are the main cause of mortality in individuals with diabetes. Hesperetin, a typical flavanone derived from citrus fruits, has shown various biological activities beneficial to health, yet its effects on diabetes-induced vascular endothelial damage remain unexplored. In the present study, hesperetin intervention improved serum lipid metabolism, ameliorated aortic endothelial pathology, reduced aortic adhesion factor expression, and enhanced glucose tolerance with attenuated insulin resistance in type 2 diabetes mellitus rats. Mechanism studies revealed that intervention with hesperetin regulated the structure of gut microbiota, resulting in lower levels of trimethylamine oxide, the metabolite of gut microbiota, which in turn reduced its damage to the vascular endothelium. Simultaneously, hepatic cholesterol homeostasis regulation by hesperetin contributes to attenuated atherogenesis. Our study indicated that hesperetin, as a dietary supplement, exhibited potential for inhibiting the development diabetes-associated vascular endothelial damage.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
